Skip to main content

Jumpcode Genomics: Jon Armstrong, Kerri McWeeny, Jonathan Bell

Jumpcode Genomics has appointed Jon Armstrong as vice president of research and development, Kerri McWeeny as vice president of marketing, and Jonathan Bell as vice president of sales.   

Armstrong most recently served as CSO for Cofactor Genomics, which he also cofounded. Prior to his role at Cofactor Genomics, Armstrong spent nearly a decade in Elaine Mardis' lab at the MCDonnell Genome Institute of Washington University in St. Louis, where he helped develop microarray, next-generation sequencing, molecular biology, and cancer genetics technologies. 

McWeeny previously served as a senior director in marketing at Illumina. She joined Illumina in 2012 and held leadership roles in global pricing strategy, marketing strategy, and communications throughout her tenure there. Prior to Illumina, she held commercial leadership roles at Mo Bio Laboratories and GenVault Corp, as well as research and development roles at Motorola Life Sciences and Abbott Laboratories. 

Bell has held positions in sales, product marketing, and regional marketing for life sciences companies such as Affymetrix, Illumina, and 10x Genomics. He most recently served as a VP for Celsee, before it was acquired by Bio-Rad. 

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.